These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 15028475

  • 1. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS, Lee CF, Hsieh DS, Chang SY.
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.
    Lee CF, Chang SY, Hsieh DS, Yu DS.
    J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345
    [Abstract] [Full Text] [Related]

  • 3. Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy.
    Lee CF, Chang SY, Hsieh DS, Yu DS.
    Cancer Gene Ther; 2004 Mar; 11(3):194-207. PubMed ID: 14973549
    [Abstract] [Full Text] [Related]

  • 4. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U.
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [Abstract] [Full Text] [Related]

  • 5. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y, Yamada H, Chen X, Ryan AA, Evanoff DP, Triccas JA, O'Donnell MA.
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL, Duan H, Peng ZP, Sun SL, Li SL.
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [Abstract] [Full Text] [Related]

  • 7. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria.
    Kuromatsu I, Matsuo K, Takamura S, Kim G, Takebe Y, Kawamura J, Yasutomi Y.
    Cancer Gene Ther; 2001 Jul; 8(7):483-90. PubMed ID: 11498769
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 9. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar 01; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 10. Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.
    Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W.
    Urology; 2005 Aug 01; 66(2):461-6. PubMed ID: 16040105
    [Abstract] [Full Text] [Related]

  • 11. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y, Ioannides CG, Chada S, Ramesh R.
    Cancer Gene Ther; 2006 Aug 01; 13(8):753-61. PubMed ID: 16543916
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64.
    Yu DS, Lee CF, Chang SY.
    J Urol; 2007 Feb 01; 177(2):738-42. PubMed ID: 17222673
    [Abstract] [Full Text] [Related]

  • 13. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
    Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K.
    Cancer Res; 2001 Feb 01; 61(3):1005-12. PubMed ID: 11221826
    [Abstract] [Full Text] [Related]

  • 14. Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice.
    Lin CW, Su IJ, Chang JR, Chen YY, Lu JJ, Dou HY.
    APMIS; 2012 Jan 01; 120(1):72-82. PubMed ID: 22151310
    [Abstract] [Full Text] [Related]

  • 15. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of interleukin-12 against murine bladder cancer.
    Eto M, Harada M, Tamada K, Tokuda N, Koikawa Y, Nakamura M, Nomoto K, Naito S.
    J Urol; 2000 May 01; 163(5):1549-52. PubMed ID: 10751886
    [Abstract] [Full Text] [Related]

  • 17. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM, Shi CH, Fan XL, Xue Y, Bai YL, Xu ZK.
    Chin Med J (Engl); 2007 Jul 20; 120(14):1220-5. PubMed ID: 17697571
    [Abstract] [Full Text] [Related]

  • 18. [The effects of rBCG expressing Der p2 in the form of lipoprotein on murine immune response].
    Shi JR, Zhang XH, Shi CH, Cao YX, Wu CG, Li Y, Fan XL, Qi HW.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May 20; 21(3):287-9. PubMed ID: 15862141
    [Abstract] [Full Text] [Related]

  • 19. Construction of recombinant human IFNα-2b BCG and its antitumor effects on bladder cancer cells in vitro.
    Sun E, Nian X, Liu C, Fan X, Han R.
    Genet Mol Res; 2015 Apr 15; 14(2):3436-49. PubMed ID: 25966110
    [Abstract] [Full Text] [Related]

  • 20. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A, Ratliff TL, Oakley DM, Catalona WJ.
    Cancer Res; 1983 Apr 15; 43(4):1611-5. PubMed ID: 6339040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.